This case report describes the clinical course of a patient with imatinib/pazopanib-resistant dermatofibrosarcoma protuberans treated with trabectedin.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Matsumura et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: